One-day Treatment with the Anticancer Drug Carboplatin is as Effective as Radiotherapy for Testicular Cancer

February 5th, 2007 India is the ideal place to conduct human trial for the effectiveness of DCA ( dichloroacetate ) as anti-cancer drug. The government regulations for human trial aren't as stringest as USA, there are funds available for such studies and frankly you don't need much.

February 27th, 2007 DCA has generated quite an interest in patients with Cancer, many even contemplating self-treatment for cure. The key points we know about DCA so far are: 1.

March 25th, 2006 According to latest news flash scientists have found mice testicles can yield embryonic stem cell like cells. A team in Germany has successfully grown mouse ESC-like cells from spermatagonial stem cells which normally turn into sperm.

July 17th, 2005 The European study of patients with Type I diabetes found that short-term treatment lowered insulin dependence by 12 percent and increased insulin-making capabilities for at least 18 months. "The results are very promising.

February 3rd, 2007 Investigators at the University of Alberta have recently reported that the drug DCA is able to cause tumor regression in a number of human cancers growing in animals. The drug, dichloroacetate (DCA), is being used for years to treat rare metabolic disorders and is known to be relatively safe.

August 13th, 2005 A cheap drug, enfurvitide, has shown promise in stamping out hidden pockets of HIV in three people who have long been infected with the virus. The result is described by the US scientists as merely a “proof of concept”, but has inevitably sparked talk of a cure for AIDS.

September 29th, 2005 The Food and Drug Administration warned doctors on Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit hyperactivity disorder (ADHD). Manufacturer Eli Lilly & Co.

April 7th, 2005 for those afflicted with Diabetic Peripheral Neuropathy (DPN), Missouri Southern Healthcare has a new therapy program that has shown great strides in returning circulation to feet, lowering the pain and frequency of falls that most people with diabetes suffer. The therapy must be given in 40-minute increments three times a week for 10 to 20 weeks.

May 23rd, 2005 University of New South Wales (UNSW) researchers are running two new studies on hepatitis C, which could revolutionise treatment for the virus. It is hoped that one study could lead to cure rates of almost 100 percent in those who have just been infected with the virus.

May 7th, 2005 Keryx Biopharmaceuticals (KERX) Announces Positive Interim Results From Phase 2 Clinical Study For KRX-101 (Sulodexide Gelcaps) For Treatment Of Diabetic Nephropathy. Around 40% of diabetic patients progress to diabetic nephropathy.

July 8th, 2005 Merck tried to patent a drug that would reduce heart attack risks for Vioxx (COX-2 selective inhibitors) users, three years before the company withdrew the painkiller drug from the market because of safety concerns. According to government records, the company applied for the patent in 2001.

August 11th, 2005 Researchers have identified excessive gambling as a side effect of a treatment for Parkinson's disease. Some patients who are prescribed medication known as dopamine agonists developed the problem within three months of starting treatment, even though they had previously gambled only occasionally or never at all.

August 3rd, 2005 Symptoms in mice that mimic Parkinson’s disease are reversed by treatment with amphetamines, including Ecstasy, according to a new study by Marc Caron of Duke University, US. The drugs seem to work through a pathway not involving the chemical dopamine, which surprised the researchers since dopamine deficiency is the cause of Parkinson’s.

November 8th, 2007 Now this is something for religious bigots, who oppose embryonic stem cell research on ethical grounds (logically unsustainable but when have bigots listened to logic?), to chew upon. Latest research on cancer indicates that the dominant mechanism of cancer cells is to behave like early embryonic stem cells.

April 14th, 2005 Researchers at Rice University in Texas have developed a new approach to fighting cancer, based on nanoscale particles that can both detect and destroy cancerous cells. The report appears in the April 13 issue of the American Chemical Society's journal Nano Letters.